Parent Categories
Health Care
-
The FDA Declares Levonorgestrel a Nonabortifacient—A 50-Year Saga Takes a Decisive Turn
December 4, 2024
Eli Y. Adashi, I. Glenn Cohen & Allen J. Wilcox, The FDA Declares Levonorgestrel a Nonabortifacient—A 50-Year Saga Takes a Decisive Turn, 8 JAMA Health…
-
I. Glenn Cohen, Eli Y. Adashi & Mary Ziegler, The New Threat to Abortion Access in the United States—The Comstock Act, 330 JAMA 405 (2023).
-
The Challenges for Regulating Medical Use of ChatGPT and Other Large Language Models
December 4, 2024
Timo Minssen, Effy Vayena & I. Glenn Cohen, The Challenges for Regulating Medical Use of ChatGPT and Other Large Language Models, 330 JAMA 315 (2023).
-
Eli Y. Adashi, Daniel P. O’Mahoney & I. Glenn Cohen, Assisted Reproduction Post-Dobbs: the Prospect of Legislative Protection, 4 F&S Reps. 128 (2023).
-
Patient-Assistance Programs, Kickbacks, and the Courts
December 4, 2024
Jacob T. Elberg, Eli Y. Adashi & I. Glenn Cohen, Patient-Assistance Programs, Kickbacks, and the Courts, 388 New England J. Med. 2407 (2023).
-
Eli Y. Adashi, Daniel P. O’Mahoney & I. Glenn Cohen, Hospital at Home Receives a New Lease on Life: A Promising if Uncertain Future, Am.
-
Navigating a Path Towards Routine Recording in the Operating Room
December 4, 2024
Alexander Langerman, Catherine Hammack-Aviran, I. Glenn Cohen et al., Navigating a Path Towards Routine Recording in the Operating Room, Annals of Surgery (2023).
-
Carmel Shachar, Romain Cadario, I. Glenn Cohen et al., HIPAA is a Misunderstood and Inadequate Tool for Protecting Medical Data, 29 Nature Med. 1900 (2023).
-
MRT in the United States
December 4, 2024
I. Glenn Cohen, Priyanka Menon & Eli Y. Adashi, MRT in the United States, in Reproduction Reborn: How Science, Ethics, and Law Shape Mitochondrial Replacement…
-
Workplace Violence in Healthcare: Protective Federal Legislation Must Not Be Delayed
December 4, 2024
Eli Y. Adashi, Daniel P. O’Mahony & I. Glenn Cohen, Workplace Violence in Healthcare: Protective Federal Legislation Must Not Be Delayed, Am. J. Med. (2023).
-
Eli Y. Adashi, Daniel P. O’Mahony & I. Glenn Cohen, The Inflation Reduction Act: Recasting the Medicare Prescription Drug Plans, Am. J. Preventative Med. (2023).
-
Eli Y. Adashi & I. Glenn Cohen, The FDA Initiative to Assure Racial and Ethnic Diversity in Clinical Trials, 36 J. Am. Bd. Fam. Med.
-
Jacob S. Sherkow, Eli Y. Adashi & I. Glenn Cohen, Assessing—and Extending—California’s Insulin Manufacturing Initiative, JAMA (2023).
-
Alliance for Hippocratic Medicine v. FDA — Dobbs’s Collateral Consequences for Pharmaceutical Regulation
December 4, 2024
Patricia J. Zettler, Eli Y. Adashi & I. Glenn Cohen, Alliance for Hippocratic Medicine v. FDA — Dobbs’s Collateral Consequences for Pharmaceutical Regulation, 388 New…
-
Reproductive Technologies and Embryo Destruction After Dobbs
December 4, 2024
I. Glenn Cohen, Reproductive Technologies and Embryo Destruction After Dobbs, in Roe v. Dobbs: The Past, Present and Future of a Constitutional Right of Abortion…
-
The Reply
December 4, 2024
Eli Y. Adashi & I. Glenn Cohen, The Reply, 136 Am. J. Med. (2023).
-
Should the Administration for Strategic Preparedness and Response Lead the National Response to a Public Health Emergency?
December 4, 2024
Eli Y. Adashi, Daniel P. O’Mahony & I. Glenn Cohen, Should the Administration for Strategic Preparedness and Response Lead the National Response to a Public…
-
Eli Y. Adashi & I. Glenn Cohen, EMTALA After Dobbs: Emergency Reproductive Health Care in the Balance, Annals Internal Med. (2023).
-
Integrity of SARS-CoV-2 Laboratory-Developed Tests—Reply
December 4, 2024
Eli Y. Adashi & I. Glenn Cohen, Integrity of SARS-CoV-2 Laboratory-Developed Tests—Reply, 328 JAMA 478 (2022).
-
Emerging Ethical Considerations for the Use of Artificial Intelligence in Ophthalmology
December 4, 2024
Nicholas G. Evans, Danielle M. Wenner, I. Glenn Cohen et al., Emerging Ethical Considerations for the Use of Artificial Intelligence in Ophthalmology, 2 Ophthalmology Sci. 1…
-
The FDA Struggle to Withdraw Makena
December 4, 2024
Daniel G. Aaron, I. Glenn Cohen & Eli Y. Adashi, The FDA Struggle to Withdraw Makena, JAMA (2022).